Manhattan Scientifics, Inc. (MHTX)

[eatbytes]

Mr. Prulx gave an interview on Austrailian radio, yesterday, that we can listen to on the Imagion Biosytems website. He announced a couple important items during his interview. The first is that they hope to have the early cancer detection technology commercially available in 3 to 5 years. The second is that they hope to begin clinical human trials in 1 to 2 years at a Australian site instead of here in the U.S.